UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection

PLoS pathogens, 2014-02, Vol.10 (2), p.e1003970-e1003970

2014

Volltextzugriff (PDF)

Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors

Oncoimmunology, 2018-05, Vol.7 (5), p.e1421891-e1421891

2018

Volltextzugriff (PDF)

Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity

Journal for immunotherapy of cancer, 2022-01, Vol.10 (1), p.e003717

2022

Volltextzugriff (PDF)

Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio

Journal for immunotherapy of cancer, 2020-11, Vol.8 (2), p.e001662

2020

Volltextzugriff (PDF)

Vaccines targeting ESR1 activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancer

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2309693-2309693

2024

Volltextzugriff (PDF)

Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis

JCI insight, 2022-03, Vol.7 (6)

2022

Volltextzugriff (PDF)

Beyond Neoantigens: Antigens Derived from Tumor Drivers as Cancer Vaccine Targets

Clinical cancer research, 2023-09, Vol.29 (17), p.3256-3258

2023

Volltextzugriff (PDF)

Cancer vaccine strategies using self-replicating RNA viral platforms

Cancer gene therapy, 2023-06, Vol.30 (6), p.794-802

2023

Volltextzugriff (PDF)

Clinical trials of self-replicating RNA-based cancer vaccines

Cancer gene therapy, 2023-06, Vol.30 (6), p.803-811

2023

Volltextzugriff (PDF)

Intratumoral Plasmid IL12 Expands CD8 + T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti-PD-1 Therapy

Clinical cancer research, 2021-05, Vol.27 (9), p.2481-2493

2021

Volltextzugriff (PDF)

Vaccine-Induced Memory CD8 + T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study

Clinical cancer research, 2019-05, Vol.25 (9), p.2725-2736

2019

Volltextzugriff (PDF)

Lymphocytic Choriomeningitis Virus Expands a Population of NKG2D+CD8+ T Cells That Exacerbates Disease in Mice Coinfected with Leishmania major

The Journal of immunology (1950), 2015-10, Vol.195 (7), p.3301-3310

2015

Volltextzugriff (PDF)

Effector T Cell Egress via Afferent Lymph Modulates Local Tissue Inflammation

The Journal of immunology (1950), 2015-10, Vol.195 (8), p.3531-3536

2015

Volltextzugriff (PDF)

CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosis

JCI insight, 2019-12, Vol.4 (24)

2019

Volltextzugriff (PDF)

Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors

Oncotarget, 2021-01, Vol.12 (1), p.1-3

2021

Volltextzugriff (PDF)

HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study

Molecular cancer therapeutics, 2022-01, Vol.21 (1), p.217-226

2022

Volltextzugriff (PDF)

HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase

Molecular cancer research, 2021-10, Vol.19 (10), p.1699-1711

2021

Volltextzugriff (PDF)

Key takeaways for knowledge expansion of early-career scientists conducting Transdisciplinary Research in Energetics and Cancer (TREC): a report from the TREC Training Workshop 2022

Journal of the National Cancer Institute. Monographs, 2023-05, Vol.2023 (61), p.149-157

2023

Volltextzugriff (PDF)

876 Self-replicating RNA therapeutics for off-the-shelf precision immunotherapy targeting acquired resistance mutations in low TMB tumors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A976-A976

2023

Volltextzugriff (PDF)

Immunosurveillance by Antiangiogenesis: Tumor Growth Arrest by T Cell-Derived Thrombospondin-1

Cancer research (Chicago, Ill.), 2014-04, Vol.74 (8), p.2171-2181

2014

Volltextzugriff (PDF)

Abstract 1557: Intratumoral plasmid IL-12 enhanced the systemic anti-tumor effect of anti-PD-1 antibody in triple-negative breast cancer

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1557-1557

2021

Volltextzugriff (PDF)

The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment

Oncogene, 2016-11, Vol.35 (47), p.6053-6064

2016

Volltextzugriff (PDF)

Intracorporeal Sonoporation-Induced Drug/Gene Delivery Using a Catheter Ultrasound Transducer

2022 IEEE International Ultrasonics Symposium (IUS), 2022, p.1-4

2022

Volltextzugriff (PDF)

Ultrasound Enhanced Perfusion and Drug Penetration for Intratumoral Immunotherapy Using a Needle Ultrasound Transducer - a Phantom Study

2023 IEEE International Ultrasonics Symposium (IUS), 2023, p.1-4

2023

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Englisch
(52)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Humans
(16)
Female
(15)
Oncology
(14)
Animals
(13)
Mice
(13)
Immunotherapy
(7)
Male
(7)
Cell Line, Tumor
(6)
Immunology
(6)
Tumors
(6)
Breast Cancer
(5)
Breast Neoplasms - Pathology
(5)
Cd8-Positive T-Lymphocytes - Immunology
(5)
Antigens
(4)
Cancer Vaccines
(4)
Cell Biology
(4)
Disease Models, Animal
(4)
Genetics & Heredity
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection

Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors

Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity

Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio

Vaccines targeting ESR1 activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancer

Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis

Beyond Neoantigens: Antigens Derived from Tumor Drivers as Cancer Vaccine Targets

Cancer vaccine strategies using self-replicating RNA viral platforms

Clinical trials of self-replicating RNA-based cancer vaccines

Intratumoral Plasmid IL12 Expands CD8 + T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti-PD-1 Therapy

Vaccine-Induced Memory CD8 + T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study

Lymphocytic Choriomeningitis Virus Expands a Population of NKG2D+CD8+ T Cells That Exacerbates Disease in Mice Coinfected with Leishmania major

Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer

Effector T Cell Egress via Afferent Lymph Modulates Local Tissue Inflammation

CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosis

Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors

HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study

HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase

Key takeaways for knowledge expansion of early-career scientists conducting Transdisciplinary Research in Energetics and Cancer (TREC): a report from the TREC Training Workshop 2022

876 Self-replicating RNA therapeutics for off-the-shelf precision immunotherapy targeting acquired resistance mutations in low TMB tumors

Immunosurveillance by Antiangiogenesis: Tumor Growth Arrest by T Cell-Derived Thrombospondin-1

Abstract 1557: Intratumoral plasmid IL-12 enhanced the systemic anti-tumor effect of anti-PD-1 antibody in triple-negative breast cancer

The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment

Intracorporeal Sonoporation-Induced Drug/Gene Delivery Using a Catheter Ultrasound Transducer

Ultrasound Enhanced Perfusion and Drug Penetration for Intratumoral Immunotherapy Using a Needle Ultrasound Transducer - a Phantom Study

Suchergebnisse filtern